A detailed history of Silvercrest Asset Management Group LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 491,185 shares of HAE stock, worth $37.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
491,185
Previous 498,089 1.39%
Holding current value
$37.1 Million
Previous $41.2 Million 4.2%
% of portfolio
0.28%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.45 - $91.58 $500,194 - $632,268
-6,904 Reduced 1.39%
491,185 $39.5 Million
Q2 2024

Aug 14, 2024

SELL
$81.24 - $97.37 $40.5 Million - $48.5 Million
-498,089 Reduced 50.0%
498,089 $41.2 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $44.1 Million - $52.8 Million
542,684 Added 119.67%
996,178 $82.4 Million
Q1 2024

May 15, 2024

BUY
$71.24 - $85.35 $32.3 Million - $38.7 Million
453,494 New
453,494 $38.7 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.